A drug strategy abandoned after causing tremors, seizures and death in animals has been revived with a redesign that makes the compound less “sticky” — allowing it to let go faster from its target in the spinal cord. In mice, the new version relieved neuropathic pain without the dangerous side effects that derailed earlier attempts, potentially opening a new path beyond opioids for chronic nerve pain.

